The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1)

EDITORIAL  INTERVENTIONAL NUCLEAR MEDICINEFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):1-3

Interventional molecular imaging

Assen S. KIROV *, Heiko SCHÖDER, Stephen B. SOLOMON, Bernhard SATTLER

HTML PDF

REVIEW  INTERVENTIONAL NUCLEAR MEDICINEFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):4-19

Interventional nuclear medicine: a focus on radioguided intervention and surgery

Daphne D. RIETBERGEN, Matthias N. VAN OOSTEROM, Gijs H. KLEINJAN, Oscar R. BROUWER, Renato A. VALDES-OLMOS, Fijs W. VAN LEEUWEN, Tessa BUCKLE *

Abstract HTML PDF

REVIEW  INTERVENTIONAL NUCLEAR MEDICINEFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):20-31

Practice and prospects for PET/CT guided interventions

Mateos BOGONI, Juliano J. CERCI, Francois H. CORNELIS, Cristina NANNI, Elena TABACCHI, Heiko SCHÖDER, Paul B. SHYN, Constantinos T. SOFOCLEOUS, Stephen B. SOLOMON, Assen S. KIROV *

Abstract HTML PDF

REVIEW  INTERVENTIONAL NUCLEAR MEDICINEFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):32-42

Lung shunt and lung dose calculation methods for radioembolization treatment planning

S. Cheenu KAPPADATH *, Benjamin P. LOPEZ, Riad SALEM, Marnix G. LAM

Abstract HTML PDF

REVIEW  INTERVENTIONAL NUCLEAR MEDICINEFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):43-50

Practical setting and potential applications of interventions guided by PET/MRI

C. Martin REICH, Bernhard SATTLER *, Thies H. JOCHIMSEN, Michael UNGER, Leon MELZER, Lisa LANDGRAF, Henryk BARTHEL, Osama SABRI, Andreas MELZER

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):51-8

Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin

Catharina M. MULDERS-MANDERS *, Ilse J. KOUIJZER, Marcel J. JANSSEN, Wim J. OYEN, Anna SIMON, Chantal P. BLEEKER-ROVERS

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):59-63

Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience

Leonardo CAMPIOTTI *, Diego DE PALMA, Luigina GUASTI, Ilaria PROSERPIO, Sabrina CASAGRANDE, Ilaria SCHIORLIN, Elena BOLZACCHINI, Matteo SUTER, Francesca OGLIARI, Alessandro SQUIZZATO

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):64-71

Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC

S. Rasoul ZAKAVI, Narjess AYATI, Samira ZARE, Abolfazl AYATI, Kayvan SADRI, Nazanin FEKRI, Bita ABBASI, Susan SHAFIEI *

Abstract HTML PDF Supplementary_Materials

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):72-8

Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma

Sha ZHU, Hui XU, Chuyu SHEN, Yingjie WANG, Wenting XU, Shihao DUAN, Hanxiao CHEN, Xuejin OU, Linyan CHEN, Xuelei MA *

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):79-87

Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions

Philippe THUILLIER *, David BOURHIS, Ulrike SCHICK, Zarrin ALAVI, Catherine GUEZENNEC, Philippe ROBIN, Véronique KERLAN, Pierre-Yve SALAUN, Ronan ABGRAL

Abstract HTML PDF Supplementary_Materials